Full-Time

Global Market Access and Pricing Dermatology Team Lead

Dupixent

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior

Cambridge, MA, USA + 1 more

More locations: Bridgewater Township, NJ, USA

Onsite presence required.

Category
Commercial Banking
Finance & Banking
Requirements
  • A minimum of a bachelor’s degree is required.
  • Advanced degree (e.g., MBA, MD or PhD) is preferred
  • Minimum 10 years with a track record of access success across multiple regions/therapeutic areas and global leadership and strategic roles to meet and surpass business objectives.
  • Excellence in leadership, driving change, cross-functional collaboration, with executive level communication skills.
  • Experience with and understanding of US, Japan and European, key emerging market health care systems and payer drivers for portfolio management, prioritization and trade-off decision is required.
  • Demonstrated ability to work effectively in close collaboration with cross-functional partners across diverse and complex payer archetypes and priorities.
  • Track record of delivering payer relevant tools with positive measurable impact on the franchise/brand financials.
  • Knowledge of the success metrics of how the value proposition is delivered to key payers (i.e., what is required to command certain benefit ratings, P&R outcomes, reimbursement, coding).
  • Both Global and country level market access experience is preferred.
  • A sound understanding on the evolution of the market access landscape and implications for the business is required.
  • Prior experience in formally leading or managing.
  • This position may require up to 20% overall travel.
Responsibilities
  • Lead a team of market access professionals to develop payer-optimized strategies and tactics for DUPIXENT, focusing on protecting access in a competitive environment, expanding access to new indications as well as within existing indications, and ensuring excellence in execution of market access tactics by affiliate national and field teams including omnichannel strategy.
  • As member of the Franchise Leadership team, contribute to the formulation and execution of the Franchise strategy and ensures key payer/ market access considerations are made explicit and addressed as appropriate.
  • Bring Payer knowledge to drive the identification of evidence needs for Market Access & Pricing optimization, especially for EIGP support of payer discussions.
  • Accountable for timely development and approval of core GMAP deliverables to ensure successful launch readiness of DUPIXENT in new dermatology indications (GMAP Strategy and Policy, MAx blueprint, PVP, Core Value Dossier, Objection handler, Negotiation Handbook).
  • Ensure collaboration with relevant internal stakeholders from different functions including Commercial, HEVA, Medical, Pricing, Public Affairs, Franchise Head and major markets.
  • Collaborate effectively with affiliates to ensure successful MAP strategy ideation and implementation in key markets.
  • Secure alignment with Alliance partners throughout strategy development and execution.
  • Responsible for the pricing and access governance (internal and Alliance), including local strategy reviews and optimization and the coordination within the BU & franchise head for key markets; reviews pricing recommendation proposed by the market liaison and CoE for other markets; secure timely approval from senior management and communicates updates and rationale internally.
  • Ensures representation of MAx on Global Brand Team.
  • Provide market access/pricing strategic input into product forecasts and partners with Global Market Access CoE to build on forecasts, pricing guidance and potential innovative contracting tools developed together with the Global Pricing CoE team.
  • Manage budget allocation to GMAP projects according to priorities and in close partnership with the GBU MAX Head and the alliance.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse product pipeline and a global presence. The company's goal is to enhance health outcomes and improve the quality of life for individuals worldwide.

Company Stage

Grant

Total Funding

$2B

Headquarters

Paris, France

Founded

N/A

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Sanofi's strong financial performance, as evidenced by its raised 2024 outlook, indicates robust growth and stability.
  • The company's strategic investments in innovative biotech firms, such as Ventyx Biosciences, enhance its pipeline and potential for breakthrough therapies.
  • Sanofi's Dupixent receiving a positive recommendation for expanded use in children demonstrates its leadership in addressing unmet medical needs.

What critics are saying

  • The highly competitive pharmaceutical market requires Sanofi to continuously innovate to maintain its market position.
  • Regulatory challenges in different regions could delay product approvals and impact revenue streams.

What makes Sanofi unique

  • Sanofi's extensive R&D efforts and strategic partnerships, such as with Orano Med for radioligand therapies, set it apart in the competitive pharmaceutical landscape.
  • The company's global reach and focus on patient-centric solutions allow it to effectively navigate diverse regulatory environments and deliver innovative treatments worldwide.
  • Sanofi's investment in sustainable initiatives, like SureChill's 'Cooling as a Service' model, highlights its commitment to addressing healthcare challenges in emerging markets.

Help us improve and share your feedback! Did you find this helpful?